VA-ECMO does not increase survival in MI-related cardiogenic shock

Nature Reviews Cardiology, Published online: 06 September 2023; doi:10.1038/s41569-023-00929-4New data from the ECLS-SHOCK trial and a meta-analysis indicate that the routine use of venoarterial extracorporeal membrane oxygenation does not increase survival in patients with myocardial infarction-related cardiogenic shock.

https://www.nature.com/articles/s41569-023-00929-4

Source: Nature Reviews Cardiology - September 6, 2023 Category: Cardiology Authors: Gregory B. Lim Source Type: research

More News: Cardiogenic Shock | Cardiology | Heart | Heart Attack